tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNAC Stock Latest News

Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis
Company AnnouncementsCartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis
15d ago
RNAC
Wedbush bullish on Cartesian Therapeutics, initiates with an Outperform
PremiumThe Fly
Wedbush bullish on Cartesian Therapeutics, initiates with an Outperform
17d ago
RNAC
Cartesian Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Cartesian Therapeutics initiated with an Outperform at Wedbush
17d ago
RNAC
Cartesian Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Cartesian Therapeutics Holds Annual Stockholders Meeting
1M ago
8K
RNAC
Cartesian Therapeutics announces employment inducement grants
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grants
2M ago
RNAC
Promising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections
PremiumRatingsPromising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections
2M ago
RNAC
Cartesian announces first participant enrolled in Phase 3 AURORA trial
Premium
The Fly
Cartesian announces first participant enrolled in Phase 3 AURORA trial
2M ago
RNAC
Cartesian selloff brings ‘attractive buying opportunity,’ says Mizuho
Premium
The Fly
Cartesian selloff brings ‘attractive buying opportunity,’ says Mizuho
3M ago
RNAC
Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising mRNA-Based CAR-T Developments and Strategic Clinical Advancements
PremiumRatings
Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising mRNA-Based CAR-T Developments and Strategic Clinical Advancements
3M ago
RNAC
Promising Potential of Cartesian Therapeutics’ Descartes-08 Therapy Drives Buy Rating
PremiumRatings
Promising Potential of Cartesian Therapeutics’ Descartes-08 Therapy Drives Buy Rating
3M ago
RNAC
Cartesian Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cartesian Therapeutics Reports Q1 2025 Financial Results
3M ago
RNAC
Buy Rating for Cartesian Therapeutics: Promising Clinical Progress and Stable Financial Outlook
PremiumRatings
Buy Rating for Cartesian Therapeutics: Promising Clinical Progress and Stable Financial Outlook
3M ago
RNAC
Cartesian Therapeutics reports Q1 EPS (68c) vs ($10.50) last year
PremiumThe FlyCartesian Therapeutics reports Q1 EPS (68c) vs ($10.50) last year
3M ago
RNAC
RNAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RNAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
RNAC
Cartesian Therapeutics announces employment inducement grants
Premium
The Fly
Cartesian Therapeutics announces employment inducement grants
3M ago
RNAC
Cartesian Therapeutics CTO Transition to Consultant Role
PremiumCompany Announcements
Cartesian Therapeutics CTO Transition to Consultant Role
3M ago
8K
RNAC
Cartesian Therapeutics management to meet with BTIG
PremiumThe Fly
Cartesian Therapeutics management to meet with BTIG
3M ago
RNAC
Seven new option listings and one option delisting on April 16th
PremiumThe Fly
Seven new option listings and one option delisting on April 16th
3M ago
AVTX
CARA
Buy Rating Affirmed for Cartesian Therapeutics Due to Promising Phase 2b Trial Results and Strong Safety Profile
PremiumRatings
Buy Rating Affirmed for Cartesian Therapeutics Due to Promising Phase 2b Trial Results and Strong Safety Profile
4M ago
RNAC
Promising Growth Potential for Cartesian Therapeutics: Buy Rating Affirmed by Analyst Gil Blum
PremiumRatingsPromising Growth Potential for Cartesian Therapeutics: Buy Rating Affirmed by Analyst Gil Blum
4M ago
RNAC
Promising Potential of Cartesian Therapeutics’ Descartes-08 in gMG Treatment: A Buy Recommendation
Premium
Ratings
Promising Potential of Cartesian Therapeutics’ Descartes-08 in gMG Treatment: A Buy Recommendation
4M ago
RNAC
Promising Clinical Data and Future Prospects Drive Buy Rating for Cartesian Therapeutics
Premium
Ratings
Promising Clinical Data and Future Prospects Drive Buy Rating for Cartesian Therapeutics
4M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >